Navigation Links
The Lancet Publishes Two-Year Results of Abbott's Fully Bioabsorbable Drug Eluting Stent
Date:3/12/2009

trial demonstrated the following key results:

  • A zero percent rate of stent thrombosis (blood clot formation) for all patients out to two years of follow up.
  • No new major adverse cardiac events (MACE) between six months and two years. At two years, the bioabsorbable device demonstrated a MACE rate of 3.6 percent (one patient). MACE is defined as any event that resulted in re-treatment of the treated artery lesion, heart attack or cardiac death.
  • Bioabsorption of the stent at two years after implantation, as confirmed by an assessment of the stent struts using optical coherence tomography (OCT).
  • Restoration of vasomotion (ability of the blood vessel to contract and expand) was observed at two years, with the drug acetylcholine used in nine patients showing vasodilation in the previously stented area, and the drug methergin used in seven patients showing vasoconstriction in the previously stented area.
  • Reduction in plaque area in treated arteries, corresponding to an increase in blood flow between six months and two years, as confirmed by intravascular ultrasound (IVUS) and virtual histology.

"Abbott's bioabsorbable stent may be a major breakthrough in the treatment of narrowed coronary arteries. The two-year ABSORB trial results show that the bioabsorbable device did its job of relieving coronary obstructions and preventing re-narrowing, and that it did this safely," said John Ormiston, M.D., medical director at Mercy Hospital in Auckland, New Zealand and principal investigator in the first phase of the ABSORB trial. "With no rigid stent remaining, vasomotion - the natural movement of the artery - was restored, and the artery appeared to behave like a normal artery. Who would want a permanent device if a temporary one may do the job and then disappear?"

Abbott is the only company with long-term clinical
'/>"/>

SOURCE Abbott
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. NeurogesX Announces Publication of Phase 3 Data for QUTENZA(TM) (NGX-4010) in Postherpetic Neuralgia (PHN) by The Lancet Neurology
2. Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet
3. Data from One-Year Liraglutide Phase 3 Study Published Online in The Lancet
4. TRANSCEND(TM) Trial Results Presented at European Society of Cardiology Congress and Published in The Lancet
5. Medivation Announces Publication in The Lancet of Dimebon Pivotal Trial Results in Alzheimers Disease
6. Pivotal Pulmonary Arterial Hypertension Study Published in The Lancet Concludes That Bosentan (Tracleer(R)) Demonstrates Benefits in Patients With Mildly Symptomatic WHO Functional Class II Disease
7. Iomai Announces Publication in The Lancet of Phase II Study Demonstrating Significant Efficacy of Travelers Diarrhea Vaccine
8. Jennerex Publishes Promising Results from Cancer Clinical Trial of JX-594 in Lancet Oncology
9. SurgiLance Safety Lancet Part of Major HIV Testing Initiative in Sub-Saharan Africa
10. International ACTEMRA Rheumatoid Arthritis Study Highlighted in The Lancet
11. New Data Published in The Lancet Show GSKs ROTARIX(R) Offers Protection Against the Most Common Circulating Rotavirus Types
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... WAYNE, Pa. , April 1, 2015 /PRNewswire/ ... fully integrated specialty pharmaceutical company focused on developing, ... the pricing of an offering of $60.0 million ... due 2020 (the "notes") in a private placement ... under the Securities Act of 1933, as amended ...
(Date:4/1/2015)... SAN CLEMENTE, Calif. , April 1, 2015 /PRNewswire/ ... residents in the United States ... out amongst their resident colleagues. In its inaugural year, ... and 50 of the top nominations were narrowed to ... voting process that saw over 10,000 votes from colleagues ...
(Date:4/1/2015)... CREEK, Calif. , April 1, 2015  For ... huge difference.  When this is the case, having the ... No one understands this truth better than software solutions ... laboratory management software QATrax.  Recently, the company announced the ... very enthusiastic response from clients. ...
Breaking Medicine Technology:Egalet Announces Pricing of $60 Million Offering of Convertible Senior Notes Due 2020 2Egalet Announces Pricing of $60 Million Offering of Convertible Senior Notes Due 2020 3Egalet Announces Pricing of $60 Million Offering of Convertible Senior Notes Due 2020 4Egalet Announces Pricing of $60 Million Offering of Convertible Senior Notes Due 2020 5Egalet Announces Pricing of $60 Million Offering of Convertible Senior Notes Due 2020 6Egalet Announces Pricing of $60 Million Offering of Convertible Senior Notes Due 2020 7Second Annual $25,000 Honorarium for Exceptional Medical Residents to Accept Nominations in April 2015 2Second Annual $25,000 Honorarium for Exceptional Medical Residents to Accept Nominations in April 2015 3Second Annual $25,000 Honorarium for Exceptional Medical Residents to Accept Nominations in April 2015 4TraxStar Technologies Announces Latest QATrax Test Lab Management Software Now Available 2
(Date:4/1/2015)... Dr. Daniel C. Stewart will be ... the benefits of the LANAP® treatment over traditional ... People who live in Howard County, and surrounding areas ... visit Dr. Stewart, a Maryland dentist, for a minimally ... protocol, which is a laser gum surgery procedure, Dr. ...
(Date:4/1/2015)... Tempaper has joined forces with the Muscular Dystrophy ... will raise critical funds to help save and improve ... United States. , Throughout the month of April, anyone ... automatically receive free domestic ground shipping on all orders ... to children and adults affected by muscular dystrophy and ...
(Date:4/1/2015)... Beach, FL (PRWEB) April 01, 2015 ... programs, continues the expansion of its executive team with ... as chief digital officer. , In his ... subscription strategy and user interface across the business and ... distribution partners and building the company’s online community. ...
(Date:4/1/2015)... Texas (PRWEB) April 01, 2015 Senior ... Best of Home Care Provider of Choice Award by Home ... Choice Award is given to home care providers who ... providers are best-in-class for quality in home care. This recognition ... your satisfaction and will provide you with quality, trustworthy in ...
(Date:4/1/2015)... Manitowoc, WI (PRWEB) April 01, 2015 Skin ... and can be cured if caught early. Forefront Dermatology and ... Midwest recognize this dangerous condition before it spreads so they ... on Saturday, April 11th from 8:30am - 12:30pm. , ... help people identify areas of concern, that could become cancerous,” ...
Breaking Medicine News(10 mins):Health News:Dr. Daniel C. Stewart Offers Columbia Area Residents an Informational Seminar in April About Less Invasive Gum Disease Treatment Now Available at Smile Savers Dentistry 2Health News:Dr. Daniel C. Stewart Offers Columbia Area Residents an Informational Seminar in April About Less Invasive Gum Disease Treatment Now Available at Smile Savers Dentistry 3Health News:Tempaper and MDA Team up in the Fight Against Muscle Disease 2Health News:Tempaper and MDA Team up in the Fight Against Muscle Disease 3Health News:Addressing The Growing Demand for Interactive, Internet Mindfulness Programs, eMindful Expands Leadership Team With Top Digital Marketing Executive 2Health News:Addressing The Growing Demand for Interactive, Internet Mindfulness Programs, eMindful Expands Leadership Team With Top Digital Marketing Executive 3Health News:Senior Helpers of Central Texas Awarded Prestigious 2015 Senior Home Care Provider of Choice Award from Home Care Pulse 2Health News:Forefront Dermatology and Dermatology Associates of Wisconsin Offers Skin Cancer Screenings on April 11th 2
... could have implications for stroke, Alzheimer,s disease , WEDNESDAY, May ... tiny blood vessels remove blood clots from the brain in ... better understanding of how to treat people who suffer from ... in the brain is crucial to allow blood to flow ...
... 2010 Complete Genomics Inc., a third-generation human genome ... owned member of the Roche Group (SIX: RO, ROG; ... services to sequence and compare a patient,s primary lung ... allow researchers to compare the patient,s genome before and ...
... a fast, simple, inexpensive method for determining whether chemicals ... in people -- a method that does not involve ... Chemical Research in Toxicology , a monthly journal. ... of public sentiment against the use of animals to ...
... Aggressive treatment of anaplastic thyroid carcinoma has dramatically increased survival ... it, say physicians at Mayo Clinic. Their findings will be ... of Clinical Oncology , to be held June 4-8 in ... need to aggressively treat metastasis even when this rare cancer ...
... People undergoing bisphosphonate therapy to prevent or treat osteoporosis ... drug and possible adverse side effects on oral health, according ... Journal of the American Dental Association (JADA). , Use ... developing bisphosphonate-associated osteonecrosis of the jaw (BON) that occurs spontaneously ...
... ... Center in the Anti-Defamation League’s (ADL’s) Southwest Region. , ... Houston, TX (Vocus) May 26, ... Medical Center in the Anti-Defamation League’s (ADL’s) Southwest Region. The Community of Respect™ ...
Cached Medicine News:Health News:Brain Cells May Serve as Clot-Busters 2Health News:Genentech uses Complete Genomics' human genome sequencing service to compare tumor and normal genome in patient with non-small cell lung cancer; results published in Nature 2Health News:New treatment approach to rare cancer results in prolonged survival 2Health News:Some bisphosphonates users unfamiliar with drug's possible side effects on oral health 2Health News:Houston Northwest Medical Center Becomes First Hospital in the Southwest Region Designated a Community of Respect™ Partner 2
... a full disclosure tape and ... analysis and unsurpassed,performance in an ... Windows 2000,XP and the fastest ... of employing,Advanced Biosensors,state-of-the-art,AB-180R digital compact ...
Olive Shaped Tip Cannula With Straight Shaft; in stainless steel....
... Designed to meet the ... of cardiology practices. The ... attenuation correction accessory features ... array that increases the ...
Sharp diamond shaped double blade in stainless steel....
Medicine Products: